Fundamental Analysis Stories

Battalion Oil Corp (BATL), an Oil & Gas industry player, has demonstrated a mixed performance in its key indicators. The company has reported a net income of $18.5M, despite a net interest income loss of $23.6M. Its EBITDA stands at a robust $220.6M, with a total revenue of $359.1M.
  over six months ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Nurix Therapeutics Inc (NASDAQ: NRIX) is currently experiencing a downtrend, which may be attributed to weak forward indicators. The company's EPS estimate for the current year stands at a loss of $3.04, while its operating margin is at -4.42. With a net income from continuing operations resulting in a loss of $180.4M, the company's financial health appears to be in a precarious state.
  over six months ago at Macroaxis 
By Rifka Kats
Rifka Kats
Sono Tek Corp (NASDAQ:SOTK), a player in the Scientific & Technical Instruments industry, presents an attractive investment opportunity despite recent market fluctuations. The company boasts a robust financial position, reflected in its strong current ratio of 3.64X and a healthy end period cash flow of $3.4M. With a total stockholder equity of $14.6M and retained earnings total equity of $4.9M, the company has demonstrated financial stability.
  over six months ago at Macroaxis 
By Rifka Kats
Rifka Kats
FingerMotion (NASDAQ: FNGR), a player in the Telecom Services industry, recently experienced a surge in its stock price. The company's market capitalization stands at $289.1M, with 44M common stock shares outstanding. Despite a negative operating margin of -0.2 and a net income loss of $7.5M, the company shows potential for growth.
  over six months ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Azure Power Global (AZRE) is currently experiencing a market dip, which may be attributed to some of its fundamental indicators. The company reported a net loss of 4.2B and a negative net interest income of 8.4B. Despite an EBITDA of 15.4B and a total revenue of 15.2B, the cost of revenue was high at 1.3B.
  over six months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
Fangdd Network Group (NASDAQ: DUO), a company operating in the Real Estate Services industry, has been demonstrating remarkable resilience amidst the market downturn. Despite a net loss of $239.6M and negative EBITDA of $246.6M, the company has managed to maintain a net asset of $1.08B. This is largely attributed to the company's robust cash flow of $182.7M at the end of the period and a significant total asset of $1.1B.
  over six months ago at Macroaxis 
By Rifka Kats
Rifka Kats
Organovo Holdings (NASDAQ:ONVO), a biotechnology firm, has seen a recent downtrend in its stock despite seemingly stable fundamental indicators. The company has a market capitalization of 15M and a book value of 2.558, with a price to book ratio of 0.6063. Despite a net asset of 33.3M, Organovo has been struggling with a net income loss of 11.4M and an EBITDA loss of 11.6M.
  over six months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Latch Inc. (LTCH), a player in the Software-Application industry, has been on a bullish run, but questions remain whether it can sustain this momentum through August. Despite the company's robust current ratio of 7.98X and a net asset of $452.3M, its operating margin stands at -3.33, indicating a significant operating loss. This is further evidenced by an EBIT of -$148.6M.
  over six months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
Nurix Therapeutics Inc. (NRIX), a key player in the Biotechnology industry, presents a compelling study of financial robustness amidst the current market uptrend. With a healthy current ratio of 5.26X and substantial total assets valued at 416.76M, the company demonstrates significant liquidity and stability. Despite a significant EBITDA loss of 179.2M and an operating income loss of 183.9M, Nurix maintains a strong cash flow of 65.4M, indicative of its ability to finance operations and invest in growth opportunities.
  over six months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
EnVVeno Medical Corp, a key player in the Medical Devices industry, has seen its stock soar, outperforming even amidst a market downturn. The company has a strong book value of $3.603 and a favorable price to book ratio of 1.28X. Despite a net loss of $24.7M and total operating expenses of $24.9M, the company maintains a healthy net tangible assets position of $38.7M and total stockholder equity of $38.7M.
  over six months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik